Loading…
Lobbying Spend
—
Filings
29
Firms Hired
1
Active Period
2020–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 2209
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R.2617
Inflation Reduction Act of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 2209
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 H.R.2617, Consolidated Appropriations Act, 2023 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 2209
H.R. 5376, the Inflation Reduction Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
Food and Drug Amendments of 2022
2022 · second_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 7667
H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 2209
H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID) S. 4348, FDA Safety and Landmark Advancements Act H.R. 7667, Food and Drug Amendments of 2022 companion diagnostics, testing, innovation, surprise billing implementation
Client expense: — · Firm income: $80,000
Matched citations: S. 4348
Inflation Reduction Act of 2022
2022 · first_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
companion diagnostics, testing, innovation, surprise billing implementation H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID)
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
companion diagnostics, testing, innovation, surprise billing implementation H.R. 5376, the Build Back Better Act S. 2209, Verifying Accurate Leading-edge IVCT Development (VALID)
Client expense: — · Firm income: $80,000
Matched citations: S. 2209
American Rescue Plan Act of 2021
2021 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
companion diagnostics payment issues H.R. 1319, American Rescue Plan of 2021 implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1319
American Rescue Plan Act of 2021
2021 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
companion diagnostics testing innovation surprise billing implementation H.R. 1319, American Rescue Plan of 2021 implementation H.R. 5376, the Build Back Better Act
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1319
Inflation Reduction Act of 2022
2021 · fourth_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
companion diagnostics testing innovation surprise billing implementation H.R. 1319, American Rescue Plan of 2021 implementation H.R. 5376, the Build Back Better Act
Client expense: — · Firm income: $80,000
Matched citations: H.R. 5376
American Rescue Plan Act of 2021
2021 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
companion diagnostics payment issues H.R. 1319, American Rescue Plan of 2021 implementation
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1319
American Rescue Plan Act of 2021
2021 · third_quarter · Firm: TARPLIN, DOWNS & YOUNG, LLC
companion diagnostics testing innovation surprise billing implementation H.R. 1319, American Rescue Plan of 2021 implementation H.R. 3, The Lower Drug Costs Now Act
Client expense: — · Firm income: $80,000
Matched citations: H.R. 1319
Source: Senate LDA